CDA and pancreatic neoplasm: This study showed that gemcitabine was protected from rapid deactivation by cytidine deaminase and increased the in vitro cytotoxicity in L3.6pl and BXPC-3 pancreatic cancer cells compared to non-conjugated gemcitabine.